Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company seeking an Associate Director Marketing, PDAC to lead the development and execution of marketing plans for the company's lead RAS(ON) programs in preparation for anticipated launches.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines